Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma

被引:38
作者
Ahmadian, A
Ren, ZP
Williams, C
Pontén, F
Odeberg, J
Pontén, J
Uhlén, M
Lundeberg, J [1 ]
机构
[1] Royal Inst Technol, Dept Biochem & Biotechnol, S-10044 Stockholm, Sweden
[2] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
p53; 9q22.3; loss of heterozygosity; squamous cell carcinoma; dysplasia;
D O I
10.1038/sj.onc.1202080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Squamous cell carcinoma (SCC) of the skin represents a group of neoplasms which is associated with exposure to UV light. Recently, we obtained data suggesting that invasive skin cancer and its precursors derive from one original neoplastic clone. Here, the analysis were extended by loss of heterozygosity (LOH) analysis in the chromosome 9q22.3 region. A total of 85 samples, taken from twenty-two sections of sun-exposed sites, corresponding to normal epidermis, morphological normal cells with positive immune-staining for the p53 protein (p53 patches), dysplasias, cancer in situ (CIS) and squamous cell carcinomas (SCC) of the skin were analysed. Overall, about 70% of p53 patches had mutations in the p53 gene but not LOH in the p53 gene or 9q22.3 region. Approximately 70% of the dysplasias showed p53 mutations of which about 40% had LOH in the p53 region but not in the 9q22.3 region. In contrast, about 65% of SCC and CIS displayed LOH in the 9q22.3 region, as well as frequent (80%) mutations and/or LOH in the p53 gene. These findings strongly suggest that alterations in the p53 gene is an early event in the progression towards SCC, whereas malignant development involves LOH and alterations in at least one (or several) tumor suppressor genes located in chromosome 9q22.3.
引用
收藏
页码:1837 / 1843
页数:7
相关论文
共 25 条
[11]   Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer [J].
Holmberg, E ;
Rozell, BL ;
Toftgard, R .
BRITISH JOURNAL OF CANCER, 1996, 74 (02) :246-250
[12]  
HULTMAN T, 1991, BIOTECHNIQUES, V10, P84
[13]   Human homolog of patched, a candidate gene for the basal cell nevus syndrome [J].
Johnson, RL ;
Rothman, AL ;
Xie, JW ;
Goodrich, LV ;
Bare, JW ;
Bonifas, JM ;
Quinn, AG ;
Myers, RM ;
Cox, DR ;
Epstein, EH ;
Scott, MP .
SCIENCE, 1996, 272 (5268) :1668-1671
[14]   DETECTION OF LOSS OF HETEROZYGOSITY AT THE HUMAN TP53 LOCUS USING A DINUCLEOTIDE REPEAT POLYMORPHISM [J].
JONES, MH ;
NAKAMURA, Y .
GENES CHROMOSOMES & CANCER, 1992, 5 (01) :89-90
[16]   Genomic analysis of single cells from human basal cell cancer using laser-assisted capture microscopy [J].
Ponten, F ;
Williams, C ;
Ling, G ;
Ahmadian, A ;
Nister, M ;
Lundeberg, J ;
Ponten, J ;
Uhlen, M .
MUTATION RESEARCH-GENOMICS, 1997, 382 (1-2) :45-55
[17]  
PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071
[18]   CHROMOSOME-9 ALLELE LOSS OCCURS IN BOTH BASAL AND SQUAMOUS-CELL CARCINOMAS OF THE SKIN [J].
QUINN, AG ;
CAMPBELL, C ;
HEALY, E ;
REES, JL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (03) :300-303
[19]  
QUINN AG, 1994, CANCER RES, V54, P4756
[20]   HIGH-FREQUENCY OF LOSS OF HETEROZYGOSITY IN ACTINIC KERATOSES, A USUALLY BENIGN DISEASE [J].
REHMAN, I ;
QUINN, AG ;
HEALY, E ;
REES, JL .
LANCET, 1994, 344 (8925) :788-789